PEG-PLA linked through a cleavable synthetic peptide sequence, PVGLIG, were prepared for targeting the tumor-associated MMP-2 enzyme, allowing a seven-fold higher release rate than when exposed to the MMP-2 enzyme at physiological conditions [24]. Here, MMP2 is linked to neoplasm.